Muhammed B. Akıncı
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study.
Journal: Future oncology (London, England)
Published: January 29, 2026
The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer.
Journal: Expert review of anticancer therapy
Published: April 09, 2025
Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis.
Journal: Cancers
Published: December 13, 2024
Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer.
Journal: Journal of clinical medicine
Published: December 06, 2024
The relationship between adjuvant chemotherapy and thiol-disulfide compounds.
Journal: Journal of cancer research and therapeutics
Published: September 23, 2022
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Journal: Turkish journal of medical sciences
Published: February 07, 2022
The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement.
Journal: Journal of cancer research and clinical oncology
Published: September 11, 2020
The association of clinicopathologic features and peripheral blood parameters with high PD-L1 expression in non-small cell lung cancer.
Journal: Tuberkuloz ve toraks
Published: August 06, 2020
Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?
Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?
Journal: Future oncology (London, England)
Published: March 12, 2019
Optimal regimen for treatment-naive hormone receptor-positive HER-2 negative metastatic breast cancer.
Journal: Future oncology (London, England)
Published: November 29, 2018
The current status of adjuvant treatment for high-risk renal cell carcinoma.
Journal: Future oncology (London, England)
Published: October 07, 2017
Last Updated: 09/26/2026